Variation in Survival After Cardiopulmonary Arrest in Cardiac Catheterization Laboratories in the United States

JACC Cardiovasc Interv. 2022 Dec 26;15(24):2463-2471. doi: 10.1016/j.jcin.2022.10.045.

Abstract

Background: In-hospital cardiac arrest during cardiac catheterization is not uncommon. The extent of variation in survival after cardiac arrest occurring in the cardiac catheterization laboratory (CCL) and underlying factors are not well known.

Objectives: The aim of this study was to identify the factors associated with higher survival rates after an index cardiac arrest in the CCL.

Methods: Within the GWTG (Get With The Guidelines)-Resuscitation registry, patients ≥18 years of age who had index in-hospital cardiac arrest in the CCL between January 1, 2003, and December 31, 2017, were identified. Hierarchical models were used to adjust for demographics, comorbidities, and cardiac arrest characteristics to generate risk-adjusted survival rates (RASRs) to discharge for each hospital with ≥5 cases during the study period. Median OR was used to quantify the extent of hospital-level variation in RASR.

Results: The study included 4,787 patients from 231 hospitals. The median RASR was 36% (IQR: 21%) and varied from a median of 20% to 52% among hospitals in the lowest and highest tertiles of RASR, respectively. The median OR was 1.71 (95% CI: 1.52-1.87), suggesting that the odds of survival for patients with identical characteristics with in-hospital cardiac arrest in the CCL from 2 randomly chosen different hospitals varied by 71%. Hospitals with greater annual numbers of cardiac arrest cases in the CCL had higher RASRs.

Conclusions: Even in controlled settings such as the CCL, there is significant hospital-level variation in survival after in-hospital cardiac arrest, which suggests an important opportunity to improve resuscitation outcomes in procedural areas.

Keywords: cardiac arrest; cardiac catheterization laboratory; survival.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cardiac Catheterization / adverse effects
  • Cardiopulmonary Resuscitation* / adverse effects
  • Heart Arrest* / diagnosis
  • Heart Arrest* / therapy
  • Hospital Mortality
  • Humans
  • Laboratories
  • Registries
  • Survival Rate
  • Treatment Outcome
  • United States / epidemiology